# Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease

> **NCT01628731** · PHASE3 · COMPLETED · sponsor: **Bambino Gesù Hospital and Research Institute** · enrollment: 74 (actual)

## Conditions studied

- Fluid Overload

## Interventions

- **DRUG:** furosemide
- **DRUG:** ethacrynic acid

## Key facts

- **NCT ID:** NCT01628731
- **Lead sponsor:** Bambino Gesù Hospital and Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-07
- **Final completion:** 2013-11
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2014-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628731, "Furosemide Versus Ethacrynic Acid in Children With Congenital Heart Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01628731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*